Contact this trialFirst, we need to learn more about you.
Nonsense Mutation Readthrough Agent
Ataluren for Duchenne Muscular Dystrophy
Recruiting2 awardsPhase 3
London, Ontario
This trial is for people with nmDBMD who have had prior exposure to ataluren in a PTC sponsored clinical trial or treatment plan, and siblings of those participants. The purpose is to see if the treatment is safe and tolerated.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.